Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme
- 1 November 2005
- journal article
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 12 (8), 930-933
- https://doi.org/10.1016/j.jocn.2004.11.017
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genesProceedings of the National Academy of Sciences of the United States of America, 2003
- Possible mechanism of dexamethasone therapy for prostate cancer: Suppression of circulating level of interleukin‐6The Prostate, 2003
- IL-6-Like Cytokines and Cancer Cachexia: Consequences of Chronic InflammationImmunologic Research, 2001
- Interleukin-6 overexpression as a marker of malignancy in human gliomasJournal of Neurosurgery, 2001
- INTERLEUKIN 6 PROMOTES VASCULOGENESIS OF MURINE BRAIN MICROVESSEL ENDOTHELIAL CELLSCytokine, 2000
- Little expression of cytokine mRNA by fresh tumour-infiltrating mononuclear leukocytes from glioma and lung adenocarcinomaCytokine, 1995
- Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in StrokeStroke, 1995
- Defective inflammatory response in interleukin 6-deficient mice.The Journal of Experimental Medicine, 1994
- Elevated levels of interleukin‐6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system invol vementArthritis & Rheumatism, 1990
- Prognostic value of round cell (lymphocyte) infiltration in malignant gliomasSurgical Neurology, 1985